FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYan Song, Sung Won Choi, John Magenau et al.|Bone Marrow Transplantation|2015Cited by 51
Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)Shalini Shenoy, Alexis A. Thompson, Lisa Murray et al.|Blood|2013Cited by 9
Effective Desensitization Strategy for Patients with Sickle Cell Disease with High Donor Specific Antibodies Undergoing Haploidentical Bone Marrow Transplant with Posttransplant CyclophosphamideEden Biltibo, Josu de la Fuente, Karina Wilkerson et al.|Blood|2022Cited by 0